Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B -receptors-Reference-Cited by-同舟云学术

Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B -receptors

Published:1998-12 Issue:6 Volume:46 Page:577-582
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Longmore ,Razzaque ,Shaw ,Davenport ,Maguire ,Pickard ,Schofield ,Hill

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.1998.00821.x/fullpdf

Reference24 articles.

1. Mode of action of the anti-migraine drug sumatriptan.;Humphrey;Tr Pharmacol Sci,1991

2. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan.;Friberg;Lancet,1991

3. Antimigraine drug sumatriptan increases blood flow velocity in cerebral arteries during migraine attacks.;Caekebeke;Neurol,1992

4. Expression of mRNA for the serotonin 5-hydroxytryptamine1Dβ receptor subtype in human and bovine cerebral arteries.;Hamel;Mol Pharmacol,1993

5. Differential distribution of 5-HT1B- and 5-HT1D-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new anti-migraine drugs.;Longmore;Cephalalgia,1997

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation and treatment of headache associated with moyamoya disease – a narrative review;Cephalalgia;2021-11-17

2. Subcutaneous sumatriptan: association with decreases in postoperative pain and opioid use after elective cranial surgery;Journal of Neurosurgery;2021-02

3. Migraine;Reference Module in Biomedical Sciences;2021

4. Cluster headache therapies: pharmacology and mode of action;Expert Review of Clinical Pharmacology;2020-06-02

5. Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system;Pain;2020-01-22